@cytonics.com
Cytonics corporation is a R&D biotech leader specializing in developing diagnostic and Alpha-2-Macroglobulin (A2M) therapies for osteoarthritis.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Cytonics Corporation is a leading biotech company dedicated to research and development in the field of regenerative medicine. Our primary focus is on osteoarthritis, and we specialize in developing diagnostic tools and therapies for this condition. One of our flagship products is the Fibronectin-Aggrecan Complex Test (FACT™), which can detect cartilage damage caused by osteoarthritis.
We licensed this groundbreaking test to Synthes (now part of Johnson & Johnson) in 2011, and it has since become a key tool for physicians in diagnosing and treating patients. Our research has also led to the discovery of a natural blood protein called Alpha-2 Macroglobulin (A2M), which protects cartilage from degradation and can relieve joint pain. Based on the function of A2M, we have developed an autologous therapy called APIC™, which has been distributed to physicians nationwide since 2015.
To date, over 6,000 patients have benefited from this innovative treatment. At Cytonics, our mission is to alleviate the pain and suffering caused by osteoarthritis and improve the quality of life for patients. We are at the forefront of regenerative medicine, and our cutting-edge biologic therapies have the potential to revolutionize the treatment of osteoarthritis.
Join us in our mission to make a difference and invest in a future free from the limitations of this debilitating condition
Company Type
Privately Held
Company Size
2-10
Year Founded
2006
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online